Portugal Telecom Sgps S.A . (PT) 4.26 $PT
Why Oi SA Is Higher Today
at The Street - Mon Mar 24, 12:32PM CDT
Shares of Oi SA (OIBR) are up 6.25% today to $1.53 as a group of five banks agreed to support plans by the Brazilian telecom firm to raise billions in new capital, guaranteeing that they will buy above 50% of the shares to be offered.
Oi S.A. - MATERIAL FACT: Consolidation of the Activities and Businesses of Oi and Portugal Telecom
PR Newswire - Thu Feb 20, 3:03AM CST
Oi S.A. ("Oi" or the "Company", Bovespa: OIBR3, OIBR4; NYSE: OIBR and OIBR.C) and Telemar Participacoes S.A. ("CorpCo"
, in accordance with article 157, paragraph 4 of Law No. 6,404/76 (the "Brazilian Corporations Law" and CVM Instruction No. 358/02, notifies their shareholders and the market in general of the previously informed transaction of the combination, in one entity, of the activities and business operations of Oi in Brazil and Portugal Telecom, SGPS, S.A. ("Portugal Telecom" in Portugal and Africa, consolidating the industrial alliance between Oi and Portugal Telecom, initiated in 2010 and developed since that time, and combining the shareholder bases of Oi, Portugal Telecom and CorpCo (the "Transaction" .
Bronchiolitis Obliterans - Pipeline Review, H2 2013 Research Report
M2 - Thu Feb 06, 2:32AM CST
Research and Markets (http://www.researchandmarkets.com/research/pd2t7t/bronchiolitis) has announced the addition of the "Bronchiolitis Obliterans - Pipeline Review, H2 2013" report to their offering. 'Bronchiolitis Obliterans - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Bronchiolitis Obliterans, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Bronchiolitis Obliterans. Scope - A snapshot of the global therapeutic scenario for Bronchiolitis Obliterans. - A review of the Bronchiolitis Obliterans products under development by companies and universities/research institutes based on information derived from company and industry-specific sources. - Coverage of products based on various stages of development ranging from discovery till registration stages. - A feature on pipeline projects on the basis of monotherapy and combined therapeutics. - Coverage of the Bronchiolitis Obliterans pipeline on the basis of route of administration and molecule type. - Key discontinued pipeline projects. - Latest news and deals relating to the products. Key Topics Covered: Introduction Bronchiolitis Obliterans Overview Therapeutics Development Pipeline Products for Bronchiolitis Obliterans - Overview Pipeline Products for Bronchiolitis Obliterans - Comparative Analysis Bronchiolitis Obliterans - Therapeutics under Development by Companies Bronchiolitis Obliterans - Therapeutics under Investigation by Universities/Institutes Bronchiolitis Obliterans - Pipeline Products Glance Late Stage Products Clinical Stage Products Bronchiolitis Obliterans - Products under Development by Companies Bronchiolitis Obliterans - Products under Investigation by Universities/Institutes Bronchiolitis Obliterans - Companies Involved in Therapeutics Development Bronchiolitis Obliterans - Therapeutics Assessment Drug Profiles cyclosporine - Drug Profile cyclosporine liposomal - Drug Profile bortezomib - Drug Profile interferon gamma-1b - Drug Profile (pentoxifylline N-acetylcysteine) - Drug Profile Bronchiolitis Obliterans - Recent Pipeline Updates Bronchiolitis Obliterans - Dormant Projects Bronchiolitis Obliterans - Product Development Milestones Featured News & Press Releases Companies Mentioned PARI Pharma GmbH Pacific Therapeutics Ltd. For more information visit http://www.researchandmarkets.com/research/pd...nchiolitis About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Oi S.A. : Material Fact - CADE's approval of the consolidation of the activities and businesses of Oi and Portugal Telecom
PR Newswire - Thu Jan 30, 5:00PM CST
Oi S.A. ("Oi" - BM&FBOVESPA: OIRBR3 and OIBR4 / NYSE: OIBR - informs its shareholders and the Market in general that the Administrative Council for Economic Defense (Conselho Administrativo de Defesa Economica), ("CADE" , the Brazilian antitrust regulator, has approved, without restrictions, the transaction subject of the Material Fact dated October 2, 2013, in connection with the consolidation of the activities and businesses of Oi and Portugal Telecom, SGPS, S.A. and that, yesterday, the deadline for third parties to lodge appeals against the decision or for CADE's Tribunal (Tribunal do CADE) to review the decision expired without manifestation by such parties. For this reason, the decision by CADE published on January 14, 2014 has been fully affirmed.
Emerging Market Sell-Off Hits Telecom, Web Stocks
at Investor's Business Daily - Fri Jan 24, 10:46AM CST
The sell-off in emerging market currencies on Friday drove down shares of Vodafone (VOD), Telefonica (TEF), America Movil (AMX), VimpelCom (VIP), satellite TV broadcaster DirecTV Group (DTV) and Latin American e-commerce firm MercadoLibre (MELI), as...
Why Rite Aid Corporation, Portugal Telecom, and YY Inc. Jumped Today
Dan Caplinger, The Motley Fool - Motley Fool - Fri Jan 03, 7:02PM CST
Although we don't believe in timing the market or panicking over daily movements, we do like to keep an eye on market changes -- just in case they're material to our investing thesis. For the second day in a row, stocks didn't deliver the...
Global Fixed Satellite Service Market 2012-2016: Currently, the Cost for the Design, Launch, and Insurance of a Satellite is More than US$200 Million
M2 - Tue Nov 05, 9:35AM CST
Research and Markets (http://www.researchandmarkets.com/research/bm53wn/global_fixed) has announced the addition of the "Global Fixed Satellite Service Market 2012-2016" report to their offering. The analysts forecast the Global Fixed Satellite Service market to grow at a CAGR of 5.44 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing demand for TV and video transponders. The Global Fixed Satellite Service market has also been witnessing the increasing number of value-enhanced services offered by FSS operators. However, the requirement for high CAPEX investment could pose a challenge to the growth of this market. The key vendors dominating this market space are Eutelsat Communications S.A., Intelsat Investment S.A., SES S.A., SKY Perfect JSAT Holdings Inc., Star One S.A., Telesat Holdings Inc., and Thaicom Public Company Ltd. Other vendors mentioned in the report are Space-Communications Ltd., APT Satellite Holdings Ltd., Arabsat Cyprus Ltd., Asia Broadcast Satellite Ltd., Asia Satellite Telecommunications Co. Ltd., Avanti Communications Group PLC., China Satellite Communications Co. Ltd., EchoStar Satellite Services LLC., JSC Gazprom Space Systems Inc., Hispasat, S.A., Intersputnik, Indian Space Research Organization, MEASAT Global Bhd., Nigerian Communications Satellites Ltd., Nilesat, Portugal Telecom, SGPS, S.A., Russia Satellite Communication Co., Satelites Mexicanos S.A., SingTel Optus Pty Ltd., and Telenor Satellite Broadcasting AS. Commenting on the report, an analyst from the team said: An increase in the utilization rate of transponders is one of the major trends being witnessed in the market in recent years. Due to government regulations and market consolidation, the capacity of the C-band and Ku-band is expected to decline by 3 percent during the forecast period. Hence, the transponder utilization of existing satellites will increase significantly. Similarly, the rate of transponder utilization has been increasing because of proper regulations for the management of desirable orbital slots. Furthermore, FSS operators are maximizing the value of their most precious, assigned, orbital slots by co-locating multiple satellites in the same slot. Hence, the increasing utilization rate of transponders is indirectly contributing to the growth of the market over the next few years. According to the report, one of the major drivers in this market is increasing demand for TV and video transponders. There are more than 30,500 TV channels worldwide at present; this number is expected to grow at a CAGR of 45 percent during the forecast period. Similarly, the number of HDTV channels will increase at a rate of 20 percent during the forecast period. There will therefore be a huge requirement for FSS transponders for TV broadcasting, video broadcasting, and content provision over the next few years. For more information visit http://www.researchandmarkets.com/research/bm...obal_fixed About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Additional Information Regarding the Industrial Alliance between Oi and Portugal Telecom
PR Newswire - Fri Oct 25, 6:45PM CDT
Oi S.A. ("Oi" , in compliance with requests made by the Brazilian Securities Commission, hereby reiterates and clarifies to its shareholders and to the market certain information related to the transactions provided in the Memorandum of Understanding for the merger of the activities of Oi and Portugal Telecom SGPS S.A. ("Portugal Telecom" (the "Transactions" , announced in the Fato Relevante dated October 2, 2013.
Hot Stock: Portugal Telecom, Shares Gain 5.1% (PT)
Comtex SmarTrend(R) - Fri Sep 20, 11:44AM CDT
Portugal Telecom (NYSE
T) is one of today's best performing low-priced stocks, up 5.1% to $4.55 on 1.1x average daily volume. Portugal Telecom has traded 402,000 shares thus far today, vs. average volume of 362,000 shares per day. The stock has outperformed the Dow (5.1% to the Dow's -0.5%) and outperformed the S&P 500 (5.1% to the S&P's -0.4%) during today's trading.
Idiopathic Pulmonary Fibrosis - Pipeline Review, H2 2013
M2 - Tue Sep 10, 3:20AM CDT
Research and Markets (http://www.researchandmarkets.com/research/4ghj69/idiopathic) has announced the addition of the "Idiopathic Pulmonary Fibrosis - Pipeline Review, H2 2013" report to their offering. 'Idiopathic Pulmonary Fibrosis - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Idiopathic Pulmonary Fibrosis, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Idiopathic Pulmonary Fibrosis. Scope - A snapshot of the global therapeutic scenario for Idiopathic Pulmonary Fibrosis. - A review of the Idiopathic Pulmonary Fibrosis products under development by companies and universities/research institutes based on information derived from company and industry-specific sources. - Coverage of products based on various stages of development ranging from discovery till registration stages. - A feature on pipeline projects on the basis of monotherapy and combined therapeutics. - Coverage of the Idiopathic Pulmonary Fibrosis pipeline on the basis of route of administration and molecule type. - Key discontinued pipeline projects. - Latest news and deals relating to the products. Companies Mentioned Bristol-Myers Squibb Company Boehringer Ingelheim GmbH Sanofi-Aventis GlaxoSmithKline plc MedImmune LLC Gilead Sciences, Inc. FibroGen, Inc. Chong Kun Dang Pharmaceutical InterMune, Inc. IntelGenx Technologies Corp. Compugen Ltd. Pharmaxis Ltd. Hanall Pharmaceutical Co., Ltd. LTT Bio-Pharma Co., Ltd. Auspex Pharmaceuticals Promedior, Inc. Mondobiotech Holding AG GenKyoTex S.A. Stromedix, Inc. ImmuneRegen BioSciences, Inc. ImmuneWorks, LLC Histocell S.L. BiOrion Technologies B.V. Pacific Therapeutics Ltd. For more information visit http://www.researchandmarkets.com/research/4ghj69/idiopathic About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
5 of Last Week's Biggest Losers
Rick Munarriz, The Motley Fool - Motley Fool - Sun Aug 18, 6:50AM CDT
There's never a shortage of losers in the stock market. Let's take a closer look at five of this past week's biggest sinkers. Company Aug. 16 Weekly Loss Vical $1.40 61% MannKind ...
Downgrade Alert for Portugal Telecom (PT)
Comtex SmarTrend(R) - Fri Aug 16, 7:07AM CDT
Portugal Telecom (NYSE T) was downgraded from Buy to Neutral at Goldman Sachs today. The stock closed yesterday at $3.85 on volume of 571,000 shares, above average daily volume of 395,000. Portugal Telecom, SGPS, S.A. offers telecommunications services in Portugal. The Company offers domestic, long distance, and international telephone, mobile telephone, paging, Internet access, and data communications services. Portugal Telecom also distributes television programming over the Internet. The Company offers some of its services in Brazil, Africa, and Asia.
Stock to Watch: Portugal Telecom Down 8.6% (PT)
Comtex SmarTrend(R) - Wed Aug 14, 10:14AM CDT
Portugal Telecom (NYSE T) is one of today's worst performing low-priced stocks, down 8.6% to $3.84 on 1.5x average daily volume. Portugal Telecom has traded 551,000 shares thus far today, vs. average volume of 377,000 shares per day. The stock has underperformed the Dow (-8.6% to the Dow's -0.5%) and underperformed the S&P 500 (-8.6% to the S&P's -0.3%) during today's trading.
Telecom and Media: A Profitable Business Partnership?
Blogs @ The Motley Fool - Motley Fool - Tue Jul 30, 7:50AM CDT
Traditional phone companies have disappeared. Telephone companies today offer wireless services, satellite television, and broadband Internet in addition to landlines. Portugal Telecom , BCE , and VIV Telefonica Brasil ...
Portugal Telecom partners with VeliQ to enable mobile workplace
M2 - Tue Jul 16, 10:55AM CDT
Portugal Telecom (NYSE: PT) and VeliQ said they have formed a commercial partnership in which Portugal Telecom will offer VeliQ's mobility Platform as a Service solution (mPaaS) to its customers in Southern Europe, Brazil, Latin America and Africa.
Portugal Telecom and VeliQ Partner to Enable the Mobile Workplace
Business Wire - Mon Jul 15, 10:17AM CDT
Portugal Telecom (NYSE: PT) and VeliQ today announced a commercial partnership whereby Portugal Telecom will offer VeliQ's mobility Platform as a Service solution (mPaaS(TM)) to its customers in Southern Europe, Brazil, Latin America and Africa.
Pacific Therapeutics Ltd. Announces Filing of Form 20F with The SEC
ACCESSWIRE - Tue Jun 18, 8:30AM CDT
VANCOUVER, BRITISH COLUMBIA- (June 18, 2013) - Mr. Doug Unwin, President and CEO of Pacific Therapeutics Ltd. (the "Company" is pleased to announce that the Company has filed a 20F Registration Statement with the United States Securities and Exchange Commission. This filing is the initial step in having the company's common shares quoted in the United States.
Portugal Telecom Up 6.1%, Shares Break Through Resistance (PT)
Comtex SmarTrend(R) - Tue Jun 04, 10:37AM CDT
Portugal Telecom (NYSE T) is one of today's best performing low-priced stocks, up 6.1% to $4.36 on 1.1x average daily volume. Thus far today, Portugal Telecom has traded 457,000 shares, vs. average volume of 434,000 shares per day. The stock has outperformed the Dow (6.1% to the Dow's -0.0%) and outperformed the S&P 500 (6.1% to the S&P's 0.0%) during today's trading.
Why Oi SA Is Higher Today
at The Street - Mon Mar 24, 12:32PM CDT
Shares of Oi SA (OIBR) are up 6.25% today to $1.53 as a group of five banks agreed to support plans by the Brazilian telecom firm to raise billions in new capital, guaranteeing that they will buy above 50% of the shares to be offered.
Oi S.A. - MATERIAL FACT: Consolidation of the Activities and Businesses of Oi and Portugal Telecom
PR Newswire - Thu Feb 20, 3:03AM CST
Oi S.A. ("Oi" or the "Company", Bovespa: OIBR3, OIBR4; NYSE: OIBR and OIBR.C) and Telemar Participacoes S.A. ("CorpCo"
, in accordance with article 157, paragraph 4 of Law No. 6,404/76 (the "Brazilian Corporations Law" and CVM Instruction No. 358/02, notifies their shareholders and the market in general of the previously informed transaction of the combination, in one entity, of the activities and business operations of Oi in Brazil and Portugal Telecom, SGPS, S.A. ("Portugal Telecom" in Portugal and Africa, consolidating the industrial alliance between Oi and Portugal Telecom, initiated in 2010 and developed since that time, and combining the shareholder bases of Oi, Portugal Telecom and CorpCo (the "Transaction" . Bronchiolitis Obliterans - Pipeline Review, H2 2013 Research Report
M2 - Thu Feb 06, 2:32AM CST
Research and Markets (http://www.researchandmarkets.com/research/pd2t7t/bronchiolitis) has announced the addition of the "Bronchiolitis Obliterans - Pipeline Review, H2 2013" report to their offering. 'Bronchiolitis Obliterans - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Bronchiolitis Obliterans, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Bronchiolitis Obliterans. Scope - A snapshot of the global therapeutic scenario for Bronchiolitis Obliterans. - A review of the Bronchiolitis Obliterans products under development by companies and universities/research institutes based on information derived from company and industry-specific sources. - Coverage of products based on various stages of development ranging from discovery till registration stages. - A feature on pipeline projects on the basis of monotherapy and combined therapeutics. - Coverage of the Bronchiolitis Obliterans pipeline on the basis of route of administration and molecule type. - Key discontinued pipeline projects. - Latest news and deals relating to the products. Key Topics Covered: Introduction Bronchiolitis Obliterans Overview Therapeutics Development Pipeline Products for Bronchiolitis Obliterans - Overview Pipeline Products for Bronchiolitis Obliterans - Comparative Analysis Bronchiolitis Obliterans - Therapeutics under Development by Companies Bronchiolitis Obliterans - Therapeutics under Investigation by Universities/Institutes Bronchiolitis Obliterans - Pipeline Products Glance Late Stage Products Clinical Stage Products Bronchiolitis Obliterans - Products under Development by Companies Bronchiolitis Obliterans - Products under Investigation by Universities/Institutes Bronchiolitis Obliterans - Companies Involved in Therapeutics Development Bronchiolitis Obliterans - Therapeutics Assessment Drug Profiles cyclosporine - Drug Profile cyclosporine liposomal - Drug Profile bortezomib - Drug Profile interferon gamma-1b - Drug Profile (pentoxifylline N-acetylcysteine) - Drug Profile Bronchiolitis Obliterans - Recent Pipeline Updates Bronchiolitis Obliterans - Dormant Projects Bronchiolitis Obliterans - Product Development Milestones Featured News & Press Releases Companies Mentioned PARI Pharma GmbH Pacific Therapeutics Ltd. For more information visit http://www.researchandmarkets.com/research/pd...nchiolitis About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Oi S.A. : Material Fact - CADE's approval of the consolidation of the activities and businesses of Oi and Portugal Telecom
PR Newswire - Thu Jan 30, 5:00PM CST
Oi S.A. ("Oi"
- BM&FBOVESPA: OIRBR3 and OIBR4 / NYSE: OIBR - informs its shareholders and the Market in general that the Administrative Council for Economic Defense (Conselho Administrativo de Defesa Economica), ("CADE" , the Brazilian antitrust regulator, has approved, without restrictions, the transaction subject of the Material Fact dated October 2, 2013, in connection with the consolidation of the activities and businesses of Oi and Portugal Telecom, SGPS, S.A. and that, yesterday, the deadline for third parties to lodge appeals against the decision or for CADE's Tribunal (Tribunal do CADE) to review the decision expired without manifestation by such parties. For this reason, the decision by CADE published on January 14, 2014 has been fully affirmed. Emerging Market Sell-Off Hits Telecom, Web Stocks
at Investor's Business Daily - Fri Jan 24, 10:46AM CST
The sell-off in emerging market currencies on Friday drove down shares of Vodafone (VOD), Telefonica (TEF), America Movil (AMX), VimpelCom (VIP), satellite TV broadcaster DirecTV Group (DTV) and Latin American e-commerce firm MercadoLibre (MELI), as...
Why Rite Aid Corporation, Portugal Telecom, and YY Inc. Jumped Today
Dan Caplinger, The Motley Fool - Motley Fool - Fri Jan 03, 7:02PM CST
Although we don't believe in timing the market or panicking over daily movements, we do like to keep an eye on market changes -- just in case they're material to our investing thesis. For the second day in a row, stocks didn't deliver the...
Global Fixed Satellite Service Market 2012-2016: Currently, the Cost for the Design, Launch, and Insurance of a Satellite is More than US$200 Million
M2 - Tue Nov 05, 9:35AM CST
Research and Markets (http://www.researchandmarkets.com/research/bm53wn/global_fixed) has announced the addition of the "Global Fixed Satellite Service Market 2012-2016" report to their offering. The analysts forecast the Global Fixed Satellite Service market to grow at a CAGR of 5.44 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing demand for TV and video transponders. The Global Fixed Satellite Service market has also been witnessing the increasing number of value-enhanced services offered by FSS operators. However, the requirement for high CAPEX investment could pose a challenge to the growth of this market. The key vendors dominating this market space are Eutelsat Communications S.A., Intelsat Investment S.A., SES S.A., SKY Perfect JSAT Holdings Inc., Star One S.A., Telesat Holdings Inc., and Thaicom Public Company Ltd. Other vendors mentioned in the report are Space-Communications Ltd., APT Satellite Holdings Ltd., Arabsat Cyprus Ltd., Asia Broadcast Satellite Ltd., Asia Satellite Telecommunications Co. Ltd., Avanti Communications Group PLC., China Satellite Communications Co. Ltd., EchoStar Satellite Services LLC., JSC Gazprom Space Systems Inc., Hispasat, S.A., Intersputnik, Indian Space Research Organization, MEASAT Global Bhd., Nigerian Communications Satellites Ltd., Nilesat, Portugal Telecom, SGPS, S.A., Russia Satellite Communication Co., Satelites Mexicanos S.A., SingTel Optus Pty Ltd., and Telenor Satellite Broadcasting AS. Commenting on the report, an analyst from the team said: An increase in the utilization rate of transponders is one of the major trends being witnessed in the market in recent years. Due to government regulations and market consolidation, the capacity of the C-band and Ku-band is expected to decline by 3 percent during the forecast period. Hence, the transponder utilization of existing satellites will increase significantly. Similarly, the rate of transponder utilization has been increasing because of proper regulations for the management of desirable orbital slots. Furthermore, FSS operators are maximizing the value of their most precious, assigned, orbital slots by co-locating multiple satellites in the same slot. Hence, the increasing utilization rate of transponders is indirectly contributing to the growth of the market over the next few years. According to the report, one of the major drivers in this market is increasing demand for TV and video transponders. There are more than 30,500 TV channels worldwide at present; this number is expected to grow at a CAGR of 45 percent during the forecast period. Similarly, the number of HDTV channels will increase at a rate of 20 percent during the forecast period. There will therefore be a huge requirement for FSS transponders for TV broadcasting, video broadcasting, and content provision over the next few years. For more information visit http://www.researchandmarkets.com/research/bm...obal_fixed About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Additional Information Regarding the Industrial Alliance between Oi and Portugal Telecom
PR Newswire - Fri Oct 25, 6:45PM CDT
Oi S.A. ("Oi"
, in compliance with requests made by the Brazilian Securities Commission, hereby reiterates and clarifies to its shareholders and to the market certain information related to the transactions provided in the Memorandum of Understanding for the merger of the activities of Oi and Portugal Telecom SGPS S.A. ("Portugal Telecom" (the "Transactions" , announced in the Fato Relevante dated October 2, 2013. Hot Stock: Portugal Telecom, Shares Gain 5.1% (PT)
Comtex SmarTrend(R) - Fri Sep 20, 11:44AM CDT
Portugal Telecom (NYSE
T) is one of today's best performing low-priced stocks, up 5.1% to $4.55 on 1.1x average daily volume. Portugal Telecom has traded 402,000 shares thus far today, vs. average volume of 362,000 shares per day. The stock has outperformed the Dow (5.1% to the Dow's -0.5%) and outperformed the S&P 500 (5.1% to the S&P's -0.4%) during today's trading. Idiopathic Pulmonary Fibrosis - Pipeline Review, H2 2013
M2 - Tue Sep 10, 3:20AM CDT
Research and Markets (http://www.researchandmarkets.com/research/4ghj69/idiopathic) has announced the addition of the "Idiopathic Pulmonary Fibrosis - Pipeline Review, H2 2013" report to their offering. 'Idiopathic Pulmonary Fibrosis - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Idiopathic Pulmonary Fibrosis, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Idiopathic Pulmonary Fibrosis. Scope - A snapshot of the global therapeutic scenario for Idiopathic Pulmonary Fibrosis. - A review of the Idiopathic Pulmonary Fibrosis products under development by companies and universities/research institutes based on information derived from company and industry-specific sources. - Coverage of products based on various stages of development ranging from discovery till registration stages. - A feature on pipeline projects on the basis of monotherapy and combined therapeutics. - Coverage of the Idiopathic Pulmonary Fibrosis pipeline on the basis of route of administration and molecule type. - Key discontinued pipeline projects. - Latest news and deals relating to the products. Companies Mentioned Bristol-Myers Squibb Company Boehringer Ingelheim GmbH Sanofi-Aventis GlaxoSmithKline plc MedImmune LLC Gilead Sciences, Inc. FibroGen, Inc. Chong Kun Dang Pharmaceutical InterMune, Inc. IntelGenx Technologies Corp. Compugen Ltd. Pharmaxis Ltd. Hanall Pharmaceutical Co., Ltd. LTT Bio-Pharma Co., Ltd. Auspex Pharmaceuticals Promedior, Inc. Mondobiotech Holding AG GenKyoTex S.A. Stromedix, Inc. ImmuneRegen BioSciences, Inc. ImmuneWorks, LLC Histocell S.L. BiOrion Technologies B.V. Pacific Therapeutics Ltd. For more information visit http://www.researchandmarkets.com/research/4ghj69/idiopathic About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
5 of Last Week's Biggest Losers
Rick Munarriz, The Motley Fool - Motley Fool - Sun Aug 18, 6:50AM CDT
There's never a shortage of losers in the stock market. Let's take a closer look at five of this past week's biggest sinkers. Company Aug. 16 Weekly Loss Vical $1.40 61% MannKind ...
Downgrade Alert for Portugal Telecom (PT)
Comtex SmarTrend(R) - Fri Aug 16, 7:07AM CDT
Portugal Telecom (NYSE
T) was downgraded from Buy to Neutral at Goldman Sachs today. The stock closed yesterday at $3.85 on volume of 571,000 shares, above average daily volume of 395,000. Portugal Telecom, SGPS, S.A. offers telecommunications services in Portugal. The Company offers domestic, long distance, and international telephone, mobile telephone, paging, Internet access, and data communications services. Portugal Telecom also distributes television programming over the Internet. The Company offers some of its services in Brazil, Africa, and Asia. Stock to Watch: Portugal Telecom Down 8.6% (PT)
Comtex SmarTrend(R) - Wed Aug 14, 10:14AM CDT
Portugal Telecom (NYSE
T) is one of today's worst performing low-priced stocks, down 8.6% to $3.84 on 1.5x average daily volume. Portugal Telecom has traded 551,000 shares thus far today, vs. average volume of 377,000 shares per day. The stock has underperformed the Dow (-8.6% to the Dow's -0.5%) and underperformed the S&P 500 (-8.6% to the S&P's -0.3%) during today's trading. Telecom and Media: A Profitable Business Partnership?
Blogs @ The Motley Fool - Motley Fool - Tue Jul 30, 7:50AM CDT
Traditional phone companies have disappeared. Telephone companies today offer wireless services, satellite television, and broadband Internet in addition to landlines. Portugal Telecom , BCE , and VIV Telefonica Brasil ...
Portugal Telecom partners with VeliQ to enable mobile workplace
M2 - Tue Jul 16, 10:55AM CDT
Portugal Telecom (NYSE: PT) and VeliQ said they have formed a commercial partnership in which Portugal Telecom will offer VeliQ's mobility Platform as a Service solution (mPaaS) to its customers in Southern Europe, Brazil, Latin America and Africa.
Portugal Telecom and VeliQ Partner to Enable the Mobile Workplace
Business Wire - Mon Jul 15, 10:17AM CDT
Portugal Telecom (NYSE: PT) and VeliQ today announced a commercial partnership whereby Portugal Telecom will offer VeliQ's mobility Platform as a Service solution (mPaaS(TM)) to its customers in Southern Europe, Brazil, Latin America and Africa.
Pacific Therapeutics Ltd. Announces Filing of Form 20F with The SEC
ACCESSWIRE - Tue Jun 18, 8:30AM CDT
VANCOUVER, BRITISH COLUMBIA- (June 18, 2013) - Mr. Doug Unwin, President and CEO of Pacific Therapeutics Ltd. (the "Company"
is pleased to announce that the Company has filed a 20F Registration Statement with the United States Securities and Exchange Commission. This filing is the initial step in having the company's common shares quoted in the United States. Portugal Telecom Up 6.1%, Shares Break Through Resistance (PT)
Comtex SmarTrend(R) - Tue Jun 04, 10:37AM CDT
Portugal Telecom (NYSE
T) is one of today's best performing low-priced stocks, up 6.1% to $4.36 on 1.1x average daily volume. Thus far today, Portugal Telecom has traded 457,000 shares, vs. average volume of 434,000 shares per day. The stock has outperformed the Dow (6.1% to the Dow's -0.0%) and outperformed the S&P 500 (6.1% to the S&P's 0.0%) during today's trading. 
